Signaling through Toll-like receptor 3 and Dectin-1 potentiates the capability of human monocyte-derived dendritic cells to promote T-helper 1 and T-helper 17 immune responses

References

• Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:245–52.
   PubMed Web of Science ®Google Scholar
• Trinchieri G, Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol. 2007;7: 179–90.
   PubMed Web of Science ®Google Scholar
• Gilboa E. DC-based cancer vaccines. J Clin Invest. 2007;117: 1195–203.
   PubMed Web of Science ®Google Scholar
• Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med. 1994;179:1109–18.
   PubMed Web of Science ®Google Scholar
• De Vries IJ, Krooshoop DJ, Scharenborg NM, Lesterhuis WJ, Diepstra JH, Van Muijen GN, . Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. Cancer Res. 2003;63:12–17.
   PubMed Web of Science ®Google Scholar
• Jonuleit H, Kuhn U, Muller G, Steinbrink K, Paragnik, L, Schmitt E, . Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol. 1997;27:3135–42.
   PubMed Web of Science ®Google Scholar
• Pedersen AE, Buus S, Claesson MH. Treatment of transplanted CT26 tumour with dendritic cell vaccine in combination with blockade of vascular endothelial growth factor receptor 2 and CTLA-4. Cancer Lett. 2006;235:229–38.
   PubMed Web of Science ®Google Scholar
• Padovan E, Landmann RM, De Libero G. How pattern recognition receptor triggering influences T cell responses: a new look into the system. Trends Immunol. 2007;28:308–14.
   PubMedGoogle Scholar
• Cella M, Salio M, Sakakibara Y, Langen H, Julkunen I, Lanzavecchia A. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J Exp Med. 1999;189:821–9.
   PubMed Web of Science ®Google Scholar
• Dennehy KM, Brown GD. The role of the beta-glucan receptor Dectin-1 in control of fungal infection. J Leukoc Biol. 2007;82: 253–8.
   PubMed Web of Science ®Google Scholar
• LeibundGut-Landmann S, Gross O, Robinson MJ, Osorio F, Slack EC, Tsoni SV, . Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat Immunol. 2007;8:630–8.
   PubMed Web of Science ®Google Scholar
• Agrawal S, Gupta S, Agrawal A. Human dendritic cells activated via Dectin-1 are efficient at priming Th17, cytotoxic CD8 T and B cell responses. PLoS One. 2010;5:e13418.
   Google Scholar
• Muzio M, Bosisio D, Polentarutti N, D'Amico G, Stoppacciaro A, Mancinelli R, . Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J Immunol. 2000;164: 5998–6004.
   PubMed Web of Science ®Google Scholar
• Verdijk RM, Mutis T, Esendam B, Kamp J, Melief CJ, Brand A, . Polyriboinosinic polyribocytidylic acid (Poly (I:C)) induces stable maturation of functionally active human dendritic cells. J Immunol. 1999;163:57–61.
   PubMed Web of Science ®Google Scholar
• Rouas R, Lewalle P, El Ouriaghli F, Nowak B, Duvillier H, Martiat P. Poly (I:C) used for human dendritic cell maturation preserves their ability to secondarily secrete bioactive IL-12. Int Immunol. 2004;16:767–73.
   PubMedGoogle Scholar
• Glimcher LH, Murphy KM. Lineage commitment in the immune system: the T helper lymphocyte grows up. Genes Dev. 2000;14:1693–711.
   PubMed Web of Science ®Google Scholar
• Ariizumi K, Shen GL, Shikano S, Xu S, Ritter R 3rd, Kumamoto T, . Identification of a novel, dendritic cell-associated molecule, Dectin-1, by subtractive cDNA cloning. J Biol Chem. 2000;275:20157–67.
   PubMed Web of Science ®Google Scholar
• Taylor PR, Brown GD, Reid DM, Willment JA, Martinez-Pomares L, Gordon S, . The beta-glucan receptor, Dectin-1, is predominantly expressed on the surface of cells of the monocyte/macrophage and neutrophil lineages. J Immunol. 2002;169: 3876–82.
   PubMed Web of Science ®Google Scholar
• Skrzypek F, Cenci E, Pietrella D, Rachini A, Bistoni F, Vecchiarelli A. Dectin-1 is required for human dendritic cells to initiate immune response to Candida albicans through Syk activation. Microbes Infect. 2009;11:661–70.
   PubMed Web of Science ®Google Scholar
• Higashi T, Hashimoto K, Takagi R, Mizuno Y, Okazaki Y, Tanaka Y, . Curdlan induces DC-mediated Th17 polarization via Jagged1 activation in human dendritic cells. Allergol Int. 2010;59:161–6.
   PubMedGoogle Scholar
• Gringhuis SI, den Dunnen J, Litjens M, van der Vlist M, Wevers B, Bruijns SCM, . Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-kappaB activation through Raf-1 and Syk Nat Immunol. 2009;10: 203–13.
   Google Scholar
• Stopinšek S, Ihan A, Wraber B, Terčelj M, Salobir B, Rylander R, . Fungal cell wall agents suppress the innate inflammatory cytokine responses of human peripheral blood mononuclear cells challenged with lipopolysaccharide in vitro. Int Immunopharmacol. 2011;11:939–47.
   PubMedGoogle Scholar
• Snijders A, Kalinski P, Hilkens CMU, Kapsenberg ML. High-level IL-12 production by human dendritic cells requires two signals. Int Immunol. 1998;10:1593–7.
   PubMed Web of Science ®Google Scholar
• Boniface K, Blumenschein WM, Brovont-Porth K, McGeachy MJ, Basham B, Desai B, . Human Th17 cells comprise heterogeneous subsets including IFN-γ producing cells with distinct properties from the Th1 lineage. J Immunol. 2010;185: 679–87.
   PubMed Web of Science ®Google Scholar
• Dennehy KM, Willment JA, Williams DL, Brown GD. Reciprocal regulation of IL-23 and IL-12 following co-activation of Dectin-1 and TLR signaling pathways. Eur J Immunol. 2009;39:1379–86.
   PubMed Web of Science ®Google Scholar
• Gerosa F, Baldani-Guerra B, Lyakh LA, Batoni G, Esin S, Winkler-Pickett RT, . Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells. J Exp Med. 2008;205:1447–61.
   PubMed Web of Science ®Google Scholar
• Hsu YMS, Zhang Y, You Y, Wang D, Li H, Duramad O, . The adaptor protein CARD9 is required for innate immune responses to intracellular pathogens. Nat Immunol. 2007;8: 198–205.
   PubMed Web of Science ®Google Scholar
• Gross O, Gewies A, Finger K, Schäfer M, Sparwasser T, Peschel C, . Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature. 2006;442:651–6.
   PubMed Web of Science ®Google Scholar
• Colonna M. All roads lead to CARD9. Nat Immunol. 2007; 8:554–5.
   PubMedGoogle Scholar
• Weck MM, Appel S, Werth D, Sinzger C, Bringmann A, Grünebach F, . hDectin-1 is involved in uptake and cross-presentation of cellular antigens. Blood. 2008;111:4264–72.
   PubMed Web of Science ®Google Scholar
• Pflanz S, Timans JC, Cheung J, Rosales R, Kanzler H, Gilbert J, . IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4 + T cells. Immunity. 2002;16:779–90.
   PubMed Web of Science ®Google Scholar
• Yoshimura T, Atsunobu T, Shinjiro H, Yoshiyki M, Ichiko K, Tatsuro, . Two-sided roles of IL-27: induction of Th1 differentiation on naive CD4 + T cells versus suppression of proinflammatory cytokine production including IL-23-induced IL-17 on activated CD4 + T cells partially through STAT3-dependent mechanism. J Immunol. 2006;177:5377–85.
   PubMed Web of Science ®Google Scholar
• Jankovic D, Trinchieri G. IL-10 or not IL-10: that is the question. Nat Immunol. 2007;8:1281–3.
   PubMed Web of Science ®Google Scholar
• Saraiva M, Christensen JR, Veldhoen M, Murphy TL, Murphy KM, O'Garra A. Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose. Immunity. 2009; 31:209–19.
   PubMedGoogle Scholar
• Ikeda H, Old LJ, Schreiber RD. The roles of IFN gamma in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev. 2002;13:95–109.
   PubMed Web of Science ®Google Scholar
• Nishimura T, Nakui M, Sato M, Iwakabe K, Kitamura H, Sekimoto M, . The critical role of Th1-dominant immunity in tumor immunology. Cancer Chemother Pharmacol. 2000;46(Suppl):S52–61.
   Google Scholar
• Miyahara Y, Odunsi K, Chen W, Peng G, Matsuzaki J, Wang RF. Generation and regulation of human CD4 + IL-17-producing T cells in ovarian cancer. Proc Natl Acad Sci USA. 2008;105:15505–10.
   PubMed Web of Science ®Google Scholar
• Kryczek I, Banerjee M, Cheng P, Vatan L, Szeliga W, Wei S, . Phenotype, distribution, generation functional and clinical relevance of Th17 cells in the human tumor environments. Blood. 2009;6:1141–9.
   Google Scholar
• Alshaker HA, Matalka KZ. IFN-γ, IL-17 and TGF-β involvement in shaping the tumor microenvironment: the significance of modulating such cytokines in treating malignant solid tumors. Cancer Cell Int. 2011;11:33.
   PubMed Web of Science ®Google Scholar
• Muranski P, Boni A, Antony PA, Cassard L, Irvine KR, Kaiser A, . Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood. 2008;112:362–73.
   PubMed Web of Science ®Google Scholar
• Martin-Orozco N, Muranski P, Chung Y, Yang XO, Yamazaki T, Lu S, . T helper 17 cells promote cytotoxic T cell activation in tumor immunity. Immunity. 2009;31:787–98.
   PubMed Web of Science ®Google Scholar